Top compounds associated with response to DTD2


Feature Type Standardized
Nominal ANOVA
mRNA lapatinib CTRPv2 pan-cancer AAC 0.047 0.2
mRNA palmostatin B CTRPv2 pan-cancer AAC -0.058 0.2
mRNA BRD-K27188169:navitoclax (2:1 mol/mol) CTRPv2 pan-cancer AAC -0.068 0.2
mRNA HC-067047 CTRPv2 pan-cancer AAC 0.048 0.2
mRNA PX-12 CTRPv2 pan-cancer AAC -0.036 0.2
mRNA doxorubicin:navitoclax (2:1 mol/mol) CTRPv2 pan-cancer AAC -0.041 0.2
mRNA selumetinib:PLX-4032 (8:1 mol/mol) CTRPv2 pan-cancer AAC -0.044 0.2
mRNA PD318088 CTRPv2 pan-cancer AAC -0.044 0.2
mRNA AM-580 CTRPv2 pan-cancer AAC 0.046 0.2
mRNA JQ-1:navitoclax (2:1 mol/mol) CTRPv2 pan-cancer AAC -0.042 0.2
Download CSV